Free tools Windows power users keep installed
One-click scans. No signup required.
Fusion CX’s ₹702 crore IPO is scheduled to open on October 14, 2026, and close on October 16. Before applying, investors should understand the price band and minimum application, how much money goes to the company versus selling shareholders, the reported financial results and valuation, and the company’s customer and geographic concentration. The figures below are drawn from secondary reporting unless stated otherwise; check the company’s October 8 red herring prospectus (RHP) for the filed terms and risk disclosures.
1. Offer terms: price band, lot size and minimum application
The book-built issue is reported at ₹702 crore, with a price band of ₹275–₹289 per share and a face value of ₹1. At the upper end, one 51-share lot costs ₹14,739 before any applicable charges. That is the minimum retail application amount at the cap; the amount at the floor is ₹14,025.
As an Amazon Associate I earn from qualifying purchases.
| Reported term | Detail |
|---|---|
| Total issue size | ₹702 crore |
| Price band | ₹275–₹289 per share |
| Lot size | 51 shares |
| One lot at ₹275 | ₹14,025 |
| One lot at ₹289 | ₹14,739 |
| Face value | ₹1 per share |
These terms were reported by ETMarkets on October 9, 2026. Confirm the final offer details in the RHP and application interface before submitting an order.
Recommended Free Tools
2. Calendar: subscription and expected listing schedule
The offer is scheduled to open Wednesday, October 14, and close Friday, October 16, 2026. Subsequent dates are expected or scheduled rather than guaranteed; processing timelines can change.
#1 Best Overall
| Event | Reported date |
|---|---|
| IPO opens | October 14, 2026 |
| IPO closes | October 16, 2026 |
| Allotment expected | October 19, 2026 |
| Refunds and demat credit scheduled | October 21, 2026 |
| Listing scheduled | October 22, 2026 |
The timetable is reported by ETMarkets and RR Investors. Check the registrar or exchange notices for any updates to allotment, credit or listing dates.
3. Proceeds: only the fresh issue raises company capital
The reported ₹702 crore issue consists of a ₹500 crore fresh issue and a ₹202 crore offer for sale (OFS). The fresh issue is reported as 1.73 crore shares; the OFS as 69.90 lakh shares. Fresh-issue proceeds go to Fusion CX, subject to the stated uses and final allocation in the RHP. OFS proceeds go to the shareholders selling shares, not to the company.
Moneycontrol reported that the company plans to use fresh proceeds to repay or prepay borrowings; invest in step-down subsidiaries Omind Technologies Inc. and Omind Technologies Private Limited to upgrade IT tools, including Arya and MindVoice; and meet acquisition-related and general corporate purposes. The exact allocations and the amount assigned to each use should be checked in the RHP. For investors, the practical question is how much capital is directed to debt reduction and technology investment, and how much is reserved for less-specific future uses.
4. Performance and valuation: read the reported numbers in context
Moneycontrol reported the following results on October 9, 2026. These are secondary-reported figures, not independently verified here against the complete RHP financial statements.
| Period | Revenue from operations | Profit after tax |
|---|---|---|
| FY25 | About ₹1,329.3 crore | About ₹74.3 crore |
| FY26 | About ₹1,818.1 crore | About ₹169.8 crore |
| Quarter ended June 2026 | About ₹490.4 crore | About ₹55.7 crore |
ETMarkets reported a price-to-earnings ratio based on FY26 diluted earnings per share of 20.51 times at ₹275 and 21.55 times at ₹289. It also reported a three-year weighted average return on net worth of 24.59%. These are reported metrics with specific calculation bases, not forecasts or standalone evidence that the IPO is attractively or poorly priced. Investors comparing the offer with listed customer-experience or business-process services companies should use comparable earnings periods and account for differences in growth, debt, client mix and geographic exposure; no peer valuation comparison is established here.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.5. Concentration and RHP checks: identify the risks before deciding
IPOinfo reports, attributing the figures to RHP disclosures, that the top five customers accounted for 39.55% of FY26 revenue and the top ten for 49.66%. It also reports that the US and Canada accounted for 85.26%. These are secondary-source claims and should be checked against the original RHP tables, definitions and period. If confirmed, they point to exposure to a limited group of customers and a concentrated geography: a lost or reduced customer relationship, or a regional disruption, could matter materially.
Fusion CX’s official RHP landing page identifies the RHP as dated October 8, 2026, and warns that investment in the equity shares involves a high degree of risk. The page also says access to the prospectus is not a recommendation to subscribe. Read the full risk-factors section and verify the details that secondary reports cannot establish, including filed financial statements, debt and cash position, proceeds allocation, concentration measures and any qualifications attached to the reported figures.
- Confirm that the offer dates, price band, lot size and issue split match the current RHP and application form.
- Separate company funding from seller proceeds: only the fresh issue provides new capital to Fusion CX.
- Assess reported growth alongside customer and geographic concentration rather than treating revenue or profit growth alone as a complete picture.
- Interpret the reported P/E using its FY26 diluted-EPS basis; do not treat it as a prediction of returns.
ETMarkets reported Nuvama Wealth Management, IIFL Capital Services and Motilal Oswal Investment Advisors as book-running lead managers, with KFin Technologies as registrar. These operational roles do not constitute a view on the investment.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
